Peripheral Blood Mononuclear Cells Profiling Revealed Biomarkers That Predict PD‐1 Inhibitor‐Induced Immune‐Related Adverse Events
ABSTRACT Immune checkpoint inhibitors (ICIs) universally enhance antitumor immunity but endanger a subgroup of patients by triggering immune‐related adverse events (irAEs). We profiled the expressions of 41 proteins on peripheral blood mononuclear cells (PBMCs) prior the initiation of immunotherapy....
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Wiley
2026-04-01
|
| Σειρά: | MedComm |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1002/mco2.70721 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
